@numantu
After looking at it into more details, I think I agree with you.
Nice mix of volume increase, optimisation of pricing and good cost control.
In the short term, not sure they can get another good quarter of cash flow given what they say about the number of pearls expected to be sold in the July-Sept quarter.
- Forums
- ASX - By Stock
- ATP
- Ann: Funding and Company Update June 2021
Ann: Funding and Company Update June 2021, page-5
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATP (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
-0.003(3.09%) |
Mkt cap ! $40.92M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.3¢ | $23.62K | 247.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5500 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 60008 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5500 | 0.093 |
1 | 54347 | 0.092 |
2 | 100781 | 0.091 |
5 | 246671 | 0.090 |
1 | 60000 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 60008 | 2 |
0.105 | 216311 | 5 |
0.110 | 205900 | 4 |
0.115 | 70000 | 1 |
0.120 | 73641 | 4 |
Last trade - 11.36am 13/08/2024 (20 minute delay) ? |
Featured News
ATP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online